Blue Turtle Bio Overview

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • (Cancelled)
  • Investors
  • 2

Blue Turtle Bio General Information


Developer of a bio-engineered probiotics therapeutics platform designed to treat rare genetic diseases through the gut. The company's probiotics therapeutics platform engineered gut microbe secretes an enzyme, glucocerebrosidase, enabling healthcare providers to treat Gaucher's disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 479 Jessie Street
  • Lower Nob Hill
  • San Francisco, CA 94103
  • United States
+1 (313) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Blue Turtle Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 23-Aug-2016 Cancelled Startup
3. Accelerator/Incubator 23-Feb-2015 00000 00000 Completed Startup
2. Grant $5K Completed Startup
1. Accelerator/Incubator 01-Jan-2012 Completed Startup
To view Blue Turtle Bio’s complete valuation and funding history, request access »

Blue Turtle Bio Executive Team (2)

Name Title Board Seat Contact Info
Nilesh Joshi Co-Founder
You’re viewing 1 of 2 executive team members. Get the full list »

Blue Turtle Bio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
IndieBio Accelerator/Incubator Minority 000 0000 000000 0
Wayne State's Warrior Fund University 000 0000 000000 0
To view Blue Turtle Bio’s complete investors history, request access »